43 — The Psychiatric Symptom as a Biological Signal: Toward an Integrated Medicine of Mind and Body Series: Synthesis and Integrated Medical Psychiatry Evidence class: Mechanistic review and hypothesis development; see cited evidence Editorial status: Third substantive revision, 17 October 2026. Not independently peer reviewed. Abstract Psychiatric symptoms are events within a biological organism, not phenomena detached from digestion, kidney function, endocrine signaling, immunity or nervous-system dynamics. This concluding paper argues for causal integration: retain useful descriptive psychiatric diagnoses while investigating whether specific systemic mechanisms initiate or maintain distinct presentations. Oxalate-associated psychiatric vulnerability is an exemplary frontier test because it joins well-demonstrated physiology to an unresolved neural extension. How a frontier hypothesis earns a place in medicine The strongest version of integrated psychiatry does not dismiss established treatments or replace diagnostic reasoning with a preferred substance. Instead, it asks what a disease label predicts and where it fails to identify the underlying process. Autoimmune encephalitis, severe electrolyte disorders, metabolic encephalopathy and certain endocrine illnesses already demonstrate that very different mechanisms can produce similar outward symptoms. The oxalate research program proposes an additional causally specific subgroup, with intestinal uptake, internal production, renal clearance and inflammatory consequences as measurable entry points. Its success depends on finding a distinctive patient population and showing a temporal pathway from measured burden to brain-relevant outcome. The field should welcome hypotheses that make risky predictions and challenge entrenched boundaries. It should reject explanations that cannot specify dose, compartment, mediator or plausible alternative. In this framework, 'controversial' means willing to investigate an overlooked cause and willing to expose it to decisive contrary evidence. It does not mean suspending the distinction between a confirmed metabolic disorder and an untested clinical extension. From description to mechanism Psychiatric diagnosis can be valuable even when its full mechanism is unknown. A diagnosis may summarize recurring symptom patterns, anticipated risks and treatments that help. It becomes incomplete when mistaken for a total causal account. A patient with hallucinations from autoimmune encephalitis, another with psychosis during severe hypothyroidism and a third with a primary psychotic disorder may share a descriptive symptom but not an underlying disease process. Precision begins by distinguishing phenotype from etiology. A hierarchy of causal confidence At one end are well-characterized syndromes such as electrolyte encephalopathy, Wilson disease, certain porphyrias and autoimmune encephalitis, where biochemical or pathological mechanisms can be specifically investigated. In the middle are complex associations such as inflammatory variation in depression, where causal effects may depend on phenotype and comorbidity. At the speculative end are proposals that ordinary dietary oxalate causes psychiatric disorders through unproven pathways. All three categories can motivate questions, but they cannot be written as though they share the same evidentiary status. Why the oxalate question matters despite uncertainty The oxalate series provides a test of intellectual discipline. It contains established intestinal chemistry, crystallization and renal injury; severe systemic oxalosis can involve extra-renal tissues; rare neurological consequences can occur through serious metabolic illness. These facts suggest a narrow inquiry into susceptible hosts. They do not prove that dietary oxalate is a common cause of psychosis, postpartum psychiatric illness, autism or depression. The Institute should treat that distinction as a virtue of frontier research rather than a concession to orthodoxy. Treatment should follow the best causal account available A patient with acute encephalopathy needs urgent medical care; a patient with confirmed endocrine disease needs appropriate treatment; a patient with severe bipolar disorder needs psychiatric care even if additional metabolic questions remain. Psychotherapy, pharmacology, sleep treatment, nutritional intervention and medical investigation are not philosophical rival camps. Their value depends on what they address in a particular patient's illness and how benefits and harms are measured over time. What the Institute can contribute An open-access research library can distinguish hypothesis, documented mechanism, contradictory evidence and practical implications more clearly than popular health commentary often does. The purpose of provocative papers is not to replace one dogma with another, but to show where current descriptions fail to explain and where new explanations could earn credibility. Each proposition should name the competing causal paths that might defeat it. An institute becomes trustworthy by preserving a record not only of promising hypotheses but of revisions and falsifications. A psychiatric symptom is an event within an organism Fear, altered perception, cognitive slowing and depressed mood are experienced psychologically, but they are also events occurring within an embodied biological system. Sleep, endocrine regulation, inflammation, nutrition, neural circuitry and systemic organ function can shape those experiences. This recognition does not eliminate meaning, relationships or lived history from psychiatry. It means that psychiatric and medical explanations can be complementary at different causal levels. A symptom may be influenced by a metabolic condition and also become reinforced by fear, avoidance or social consequences. Neither level is automatically the whole story. The difficulty is deciding which biological story is actually true. The same symptom can arise through many pathways, and many measured abnormalities accompany illness without causing it. A research institute committed to terrain medicine should therefore demand more from its theories than biological plausibility. It should identify the exposure, intermediate mechanisms, susceptible host, temporal sequence and expected outcome. It should ask what finding would distinguish that pathway from competing explanations and accept cases in which the proposed mechanism is absent. The oxalate thesis as a test case Oxalate provides a striking example because its best-established disease pathways are outside conventional psychiatry. Enteric hyperoxaluria, primary hyperoxaluria, calcium oxalate nephropathy and rare systemic oxalosis demonstrate that oxalate handling can produce serious pathology. Experimental work establishes crystal-related inflammatory mechanisms in renal tissue. A small autism case–control study reported higher plasma and urinary oxalate in its autistic group. These observations justify a focused program asking whether some neuropsychiatric disturbances are caused or amplified by abnormal oxalate burden. They do not yet establish the answer for common psychiatric disorders. The most promising approach is to define susceptible phenotypes rather than claim universal causation. A patient with proven hyperoxaluria and renal dysfunction presents a different causal landscape from a healthy person eating a spinach salad. A person with marked fat malabsorption may absorb oxalate differently from a person with intact digestion. A patient with acute confusion deserves immediate workup for delirium and metabolic illness, regardless of dietary history. Making these distinctions does not retreat from the hypothesis; it sharpens the conditions under which the hypothesis might prove true. A standard for integrating established and frontier medicine For established metabolic psychiatric mimics, clinicians already have diagnostic strategies and appropriate treatment pathways. For speculative oxalate-related psychiatric mechanisms, the research priorities are replicated exposure measurements, credible tissue transport, intermediary biomarkers, carefully defined clinical endpoints and intervention studies designed to distinguish oxalate effects from concurrent changes in illness or diet. An observation can be promising while still being inconclusive. Public-facing publication should use that language transparently, especially when vulnerable patients might interpret a hypothesis as an established diagnosis or cure. There is a deeper possibility in this framework: multiple modest biological burdens may interact, so a substance inconsequential in one patient contributes to illness in another. That proposition is plausible at the level of systems physiology. To become specific medical knowledge, investigators would need to identify the interacting burdens in advance and show a reproducible, non-additive effect rather than invoke “multiple hits” after the fact. The future of integrated psychiatry depends on this movement from broad systems language toward predictive, testable models. The final invitation is to regard unusual psychiatric symptoms as reasons for careful inquiry without assuming that every finding has a hidden dietary cause. The scientific ambition is to explain more of the real variance in human illness—while preserving emergency recognition, effective treatment and the humility to revise a theory when the data do not cooperate. The next decade of research should be organized around discriminating comparisons A useful program would not begin by enrolling everyone with psychiatric symptoms into one undifferentiated oxalate study. It would compare biologically meaningful groups: confirmed enteric hyperoxaluria with preserved renal function, severe oxalate-associated renal disease, rare primary hyperoxaluria and appropriate non-oxalate clinical comparators. Within each group, investigators could measure specific neurological or psychiatric phenotypes, alongside sleep, nutrition, medication and systemic illness. Results might reveal a direct association, an indirect renal effect, or no distinctive relation. All three possibilities would improve the causal map. This approach can be extended to the other topics in the volume. Autoimmune encephalitis demonstrates a direct immune–neurological mechanism; thyroid disease demonstrates established endocrine contributions; hyperammonemia and hyponatremia demonstrate systemic chemical effects on brain function. The challenge is to identify when a new proposed pathway has evidence comparable in kind, not merely resemblance in language. A published essay should be explicit about whether it is presenting clinical observation, laboratory evidence, epidemiologic association or a proposed causal link. Readers can then be invited into the hypothesis without being told that an unanswered question is a settled medical fact. Conclusion The Institute's most valuable contribution can be a disciplined program of bold causal hypotheses. Oxalate–psychiatry should be argued as a plausible, testable frontier model, while established biological psychiatric disorders receive the clinical priority their evidence warrants. Selected readings - Pollak et al., Autoimmune psychosis consensus: https://pubmed.ncbi.nlm.nih.gov/31669058/ - Bousman et al., CPIC pharmacogenetics: https://pmc.ncbi.nlm.nih.gov/articles/PMC10564324/ - Witting et al., Enteric Hyperoxaluria: https://pmc.ncbi.nlm.nih.gov/articles/PMC8011014/ - Mulay et al., NLRP3 renal injury: https://doi.org/10.1172/JCI63679